Anemia Therapy
Research findings from Duke University, Duke Clinical Research Institute update understanding of anemia therapy
Published in Hepatitis Weekly, May 7th, 2007
New research, "Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy," is the subject of a report. "Anemia is a common side effect that begins soon after the initiation of peginterferon/ribavirin in the treatment of hepatitis C virus (HCV) infection. It can cause symptoms that negatively impact quality of life (QOL) and is the most common reason for reducing the dose and temporarily or permanently discontinuing ribavirin," researchers in the United States report.
"Such dose modifications have been shown to reduce the efficacy of treatment. Administering erythropoietin can improve anemia caused by peginterferon and ribavirin therapy and is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-05-07)
More Articles from Hepatitis Weekly
- Cancer Vaccines
Largest Healthcare Campaign for Asian and Pacific Islanders in the U.S. - DNA Vaccines
VGX Pharmaceuticals Announces DNA Vaccines License Agreement with University of Pennsylvania - HIV/AIDS
Gilead Sciences Announces First Quarter 2007 Financial Results - Sepsis
Iapyx Medical Introduces Stable-Line Family of Catheter Stabilization Devices Designed to Minimize Complications and Infections - Hepatitis A Virus Epidemiology
Research on hepatitis A virus epidemiology published by scientists at Scientific Institute of Public Health - Hepatitis B Virus
Beijing Institute of Radiation Medicine reports research in hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
